Revelation Biosciences Inc Capital Reinvestment Ratio
Revelation Biosciences Inc capital reinvestment ratio. Revelation Biosciences Inc (REVB) has a Capital Reinvestment Ratio of 0.04x as of December 2018, meaning it reinvests 0% of its operating cash flow ($8.43 Million) in capital expenditures ($349.00K). Check Revelation Biosciences Inc (REVB) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Revelation Biosciences Inc (2015–2019)
Capital reinvestment ratio of Revelation Biosciences Inc from 2015 to 2019. This chart tracks Revelation Biosciences Inc's Capital Reinvestment Ratio across 5 annual periods. Also explore Revelation Biosciences Inc net asset momentum to track the company's year-over-year net asset growth rate.
Revelation Biosciences Inc Capital Reinvestment Ratio by Year (2015–2019)
Revelation Biosciences Inc capital reinvestment ratio by year from 2015 to 2019. For the full cash flow conversion analysis, see how efficiently does Revelation Biosciences Inc generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.01x | $41.09 Million | $526.00K | ▼ -51.6% |
| 2018 | 0.03x | $32.58 Million | $861.00K | ▼ -20.3% |
| 2017 | 0.03x | $24.25 Million | $804.00K | ▼ -33.9% |
| 2016 | 0.05x | $11.60 Million | $582.00K | ▲ +0.0% |
| 2015 | 0.05x | $11.60 Million | $582.00K | — |